Skip to main navigation Skip to search Skip to main content

Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study.

Translated title of the contribution: Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study.
  • H.C.T. van Zaanen
  • , H.M. Lokhorst
  • , L.A. Aarden
  • , H.J.A.M. Rensink
  • , S.O. Warnaar
  • , J. van der Lelie
  • , R.H.J. van Oers

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionChimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study.
Original languageUndefined/Unknown
Pages (from-to)783-790
Number of pages8
JournalBritish Journal of Haematology
Volume102
Publication statusPublished - 1998

Cite this